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Abstract
Background: The hepadnaviral reverse transcriptase can synthesize DNA on its native RNA
template within viral cores but it is usually unable to synthesize DNA employing exogenous nucleic
acids as a template. The mechanism of this template commitment is unknown. Here we provide
evidence that the RNAseH activity of duck hepatitis B virus reverse transcriptase may also be
unable to act on exogenous substrates.
Results: RNAseH assays were performed under a wide variety of conditions employing substrate
RNAs of Duck Hepatitis B Virus sequence annealed to complementary DNA oligonucleotides and
permeabilized intracellular viral core particles. Temperature, pH, cation type, salt concentration,
substrate concentration, and the sequences of the cleavage sites were varied, and the effects of
ATP and dNTPs on RNAseH activity were examined. duck hepatitis B virus RNAseH activity was
not detected under any of these conditions, although E. coli or Avian Myeloblastosis Virus RNAseH
activity could be detected under all conditions. Access of the RNA substrate to the enzyme within
the viral cores was confirmed.
Conclusions: These results imply that the RNAseH activity of the DHBV reverse transcriptase
may not be able to degrade exogenous RNA:DNA heteroduplexes, although it can degrade
heteroduplexes of the same sequence generated during reverse transcription of the endogenous
RNA template. Therefore, the RNAseH activity appears to be "substrate committed" in a manner
similar to the template commitment observed for the DNA polymerase activity.
Background
Hepadnaviruses are small, enveloped hepatotropic viruses
which replicate by reverse transcription of a pregenomic
RNA molecule [1; for reviews see 2,3,4]. The replication of
hepadnaviral DNA is initiated by the interaction of the vi-
ral reverse transcriptase (P) with an RNA stem-loop (∈ )
within a terminal duplication of the pregenomic RNA. P
binds to the 5' copy of ∈  and then begins DNA synthesis,
using a tyrosine residue near its own amino-terminus as a
primer. DNA synthesis arrests after 3–4 nucleotides, and
then the protein-linked nascent minus-strand DNA is
transferred to the copy of direct repeat 1 (DR1) within the
3' terminal duplication. This nascent DNA then acts as a
primer for the synthesis of full length minus-strand DNA
templated by the pregenomic RNA [5,6,7,8,9,10]. During
synthesis of the minus-strand DNA the pregenomic RNA
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is degraded by the ribonuclease H (RNAseH) activity of P.
However, the RNAseH activity does not digest the extreme
5' end of the template RNA, and this ∼  18 nucleotide
capped RNA fragment is then transferred to direct repeat 2
(DR2), where it acts as a primer for synthesis of plus-
strand DNA [11, 12].
The hepadnaviral P protein possesses many unique fea-
tures relative to the better studied reverse transcriptases of
the retroviruses: (i) it uses its own amino-terminal do-
main as a protein primer for initiation of DNA synthesis
[7, 9, 10], (ii) it cannot be isolated in an active form from
virions without partial proteolysis or denaturation
[13,14,15], and (iii) under normal circumstances it is ac-
tive only on the endogenous pregenomic RNA that is en-
capsidated with it in the viral cores [16]. The mechanism
of this template commitment is unknown, although the
covalent linkage between P and the viral DNA is likely to
contribute to it.
RNAseH cleaves the RNA strand in a RNA:DNA heterodu-
plex, but it does not cleave DNA or RNA that is not hybrid-
ized to DNA. The RNAseH activity of P is required to
remove the RNA pregenome after it has been copied into
DNA during reverse transcription. If there is no RNAseH
activity, positive polarity DNA cannot be synthesized and
no infectious virions are produced. The hepadnaviral
RNAseH activity has not yet been directly measured in vi-
ral core particles, however, its existence is inferred from
four observations, (i) Sequence alignment of P with
known RNAseH enzymes reveals conserved motifs in P
[17,18,19,20]. (ii) Mutation of the putative RNAseH ac-
tive site residues in both Hepatitis B Virus (HBV) and duck
hepatitis B virus (DHBV) P blocks synthesis of mature
hepadnaviral DNA and results in the expected RNA:DNA
heteroduplex [19,21,22,23]. (iii) RNAseH activity has
been detected for the human hepatitis B virus when the
RNAseH domain was expressed as a fusion with the mal-
tose binding protein [24]. (iv) RNAseH activity has been
detected in activity gels employing purified DHBV cores,
but the apparent molecular weight of the RNAseH was less
than that of the native DHBV P, indicating that P was ei-
ther cleaved prior to the assay, or that the signal came
from a cellular RNAseH [25].
In this study we attempted to directly detect the RNAseH
activity of DHBV P within viral cores employing exoge-
nous substrates. Extensive efforts employing a wide range
of conditions and substrates yielded no DHBV RNAseH
activity. Because genetic and biochemical analyses indi-
cate that P possesses an intrinsic RNAseH activity, we con-
clude that the hepadnaviral RNAseH activity is likely to be
"substrate committed" in a manner similar to the tem-
plate commitment observed for its DNA polymerase activ-
ity.
Results
RNAseH activity on endogenous nucleic acids
To demonstrate that the DHBV P protein possesses an
RNAseH activity that is active on RNA:DNA heteroduplex-
es generated during reverse transcription, we altered P
amino acid 715 from aspartic acid to valine (D715V)
within the RNAseH domain of P and examined the effect
of this mutation on reverse transcription in viral core par-
ticles. Because no cell line exists that can be infected with
DHBV, viral core particles were produced by transfection
of DHBV DNAs into LMH cells (a chicken hepatoma cell
line). LMH cells transfected with the appropriate expres-
sion vectors (e.g., D1.5G and its derivatives) produce core
particles competent for reverse transcription and also se-
crete infectious virions [26]. Viral DNA was purified from
intracellular core particles by proteinase K digestion, phe-
nol and chloroform extraction, and ethanol precipitation.
The DNAs were then examined by Southern analysis using
strand-specific RNAs as probes. Figure 1 shows the expect-
ed distribution of forms from cells transfected with wild-
type DHBV DNA (lanes 2 and 6). As expected, transfection
of cells with DHBV DNA carrying the YMHA polymerase
active-site mutant ablated all DNA synthesis (lanes 4 and
8). Transfection of cells with DNA carrying the D715V
mutation inhibited DNA synthesis during minus-strand
DNA synthesis, yielding immature minus-polarity DNAs
(lane 3), and it also ablated positive polarity DNA synthe-
sis (lane 7). Analysis of the DNAs on denaturing gels re-
vealed that the negative polarity DNA synthesized by the
D715V mutant was annealed to a complementary strand
[23], indicating that it was in an RNA:DNA heteroduplex.
This is the predicted phenotype for an RNAseH-deficient
hepadnaviral P protein, and it indicates that the P protein
has an RNAseH activity that acts on endogenously synthe-
sized RNA:DNA heteroduplexes.
Oligonucleotide-directed RNAseH assays
To examine DHBV RNAseH activity on exogenous sub-
strates, internally 32P-labeled RNAs were synthesized in
vitro and annealed to complementary DNA oligonucle-
otides. RNAseH activity was detected as cleavage of the
RNA at the position of the hybridized oligonucleotide.
The first region selected for this oligonucleotide-directed
RNAseH assay was positive sense RNA derived from
DHBV nt 2401 to 2605 (DRF+), which contains DR2,
DR1, and the 5' half of ∈ . This RNA was chosen as it con-
tains the region where the DHBV RNAseH activity likely
initiates during reverse transcription. Oligonucleotide
D2507- was annealed to DRF+ RNA, and cleavage of this
substrate by E. coli RNAseH yielded products of 152 nt
and 93 nt (Fig. 2 lane 1). An overlapping oligonucleotide
of positive polarity that cannot anneal to the DRF+ RNA
(D2526+) was used as a negative control, and no cleavage
of the RNA was detected under these conditions (lane 2).BMC Microbiology 2001, 1 http://www.biomedcentral.com/1471-2180/1/12
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The detection limit of this assay was less than 0.00001 U
E. coli RNAseH (data not shown).
Viral cores prepared from LMH cells transfected with DH-
BV, DHBV-D715V, and DHBV-YMHA were employed
with DRF+ RNA in the oligonucleotide-directed RNAseH
assay in the first attempt to detect DHBV RNAseH activity
on exogenous substrates. The DHBV sample contained 8
×  109 genome equivalents, as determined by slot-blot hy-
bridization of core-derived nucleic acids. Because hepad-
naviral core particles are impermeable to large molecules,
they were treated with low pH prior to the RNAseH assays
to allow the substrate access to P within the cores [16]. No
RNAseH activity was detected with the viral cores in reac-
tions containing the complementary negative polarity ol-
igonucleotide (Fig. 2, lanes 3, 5, 7). As expected, there was
no cleavage in the negative control reactions employing
the noncomplementary positive polarity oligonucleotide
(lanes 4, 6, 8).
Five controls were performed to ensure that these negative
results were not artifacts. First, to ensure the presence of
enzymatically active DHBV P, viral core particles were
monitored for DNA polymerase activity on the endog-
enous nucleic acids within the core particles (the endog-
enous polymerase assay; Fig. 3A). Second, to limit the
possibility that the failure to detect RNAseH activity was
due to insufficient number of viral core particles, an
RNAseH assay was performed with a 10-fold increase in
cores. Again, no DHBV RNAseH activity was detected (da-
ta not shown). Third, permeabilization of the cores was
monitored by treating an aliquot of the permeabilized
cores with micrococcal nuclease and then measuring DNA
synthesis by the endogenous polymerase assay. Micrococ-
cal nuclease cannot gain access to the nucleic acids within
unpermeabilized cores, and hence DNA synthesis would
be unaffected if the permeabilization failed. However,
DNA synthesis was ablated by micrococcal nuclease treat-
ment of permeabilized cores, indicating that permeabili-
zation was successful (data not shown). Fourth, to control
for possible inactivation of the RNAseH active site by low
pH treatment, cores were permeabilized by treatment
with 1 M NaCl or 0.3%SDS/1% NP-40 [16], again with-
Figure 1
Mutating the DHBV P RNAseH domain yields an RNAseH
deficient phenotype. DHBV viral cores were produced in
LMH cells transfected with wild-type DHBV DNA or DHBV
DNAs carrying mutations in the P gene (D715V in the
RNAseH domain or YMHA in the reverse transcriptase
domain). Viral DNA was isolated by proteinase K digestion,
phenol and chloroform extraction, and ethanol precipitation.
Viral DNAs were detected by Southern analysis with strand-
specific riboprobes covering DHBV nt 170-3021; the left
panel shows negative-polarity DHBV DNAs and the right
panel shows positive polarity DNAs. DHBV monomer DNA
is a 3021 bp EcoRI monomer of cloned DHBV DNA, RC
DNA is mature relaxed circular DNA, DL DNA is duplex lin-
ear DNA, SS DNA is full-length single-stranded DNA.
Figure 2
DHBV RNAseH activity is unable to act on exogenous sub-
strates. Permeabilized DHBV core particles and core parti-
cles containing P mutants D715V and YMHA were used in
the RNAseH assays, and the products were resolved on a 6%
denaturing polyacrylamide gel. + indicates a complementary
oligonucleotide was included in the reaction; - indicates that
an oligonucleotide was the same polarity as the template was
included in the reaction; RNAseH indicates E. coli RNAseH;
'No core' indicates the DHBV cores were omitted from the
reaction. The sizes of the substrate (265 nt) and its cleavage
products (152 nt and 93 nt) are marked with arrows.BMC Microbiology 2001, 1 http://www.biomedcentral.com/1471-2180/1/12
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out yielding detectable RNAseH activity (data not shown).
Finally, the ability of the RNAseH substrate to access P
within the viral cores was verified using the recently re-
ported ability of DHBV P to synthesize limited amounts of
DNA from an exogenous RNA following removal of the
endogenous nucleic acids (the trans reaction [27]). The
Figure 3
DHBV core particles contain enzymatically active P that can synthesize DNA employing the RNAseH substrates as templates.
(A) Endogenous polymerase assay in permeabilized DHBV core particles. Viral cores were permeablized by brief treatment at
pH 2.5. Following neutralization, the cores were incubated with [α -32P]dNTPs and then the viral DNAs were isolated by pro-
teinase K digestion, phenol and chloroform extraction, and ethanol precipitation. DNA synthesized by P within the cores was
separated on a 1.2% agarose gel and detected by autoradiography. Lane 1: wild-type DHBV cores; lane 2: polymerase mutant
YMHA cores. RC: relaxed circular DNA; DL, duplex linear DNA; SS, single strand DNA. (B) Reverse transcriptase activity
using the exogenous RNAseH substrate as a template (the trans-reaction). Viral cores were permeabilized and the endogenous
nucleic acids were removed with micrococcal nuclease. The trans reaction was performed with the indicated exogenous
nucleic acids. The products were purified by phenol and chloroform extraction and were resolved by denaturing polyacryla-
mide electrophoresis. Lane 1 contains internally 32P -labeled DRF+ RNA as a marker. Complementary Oligo, oligonulceotide
D2507-; Noncomplementary Oligo, oligonucleotide D2526+. Lane 4 contains the RNAseH substrate (DRF+ RNA annealed to
oligonucleotide D2507-). Sizes of single-stranded marker RNAs are indicated.BMC Microbiology 2001, 1 http://www.biomedcentral.com/1471-2180/1/12
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trans reaction is template-dependent reverse transcription
of the exogenous RNA that does not depend on the pro-
tein-primed initiation mechanism of the hepadnaviruses
[28]. In the trans reaction the nucleic acids within perme-
abilized DHBV cores were degraded by micrococcal nucle-
ase, and then the nuclease was inactivated by addition of
EGTA. DRF+ RNA and radioactive dNTPs were added, the
mixture was incubated at 37°C to allow DNA synthesis,
and the products were purified and resolved by denatur-
ing polyacrylamide electrophoresis. The results (Fig. 3B
lane 2) showed that DNA was synthesized by core parti-
cles employing DRF+ as a template, indicating that the
RNA had access to P within the particles. The complemen-
tary oligonucleotide D2507- did not support DNA synthe-
sis (lane 3). The RNAseH substrate itself (DRF+ RNA
annealed to D2507-) also supported DNA synthesis in the
trans assay (lane 4), as did the combination of DRF+ RNA
and the non-complementary oligonucleotide D2526+
(lane 5). The identity of the additional band at the bottom
of Lane 4 that is absent from similar reactions lacking the
complementary oligonucleotide (Lanes 2 and 5) is un-
known. It is likely the result of an additional stop site for
reverse transcription that is present when the oligonucle-
otide is bound to the RNA rather than extension from the
oligonucleotide because we have never detected oligonu-
cleotide-dependent priming with the DHBV polymerase
under any conditions. The key feature of this important
control is the detection of DNA synthesis using the
RNAseH template as a substrate, because it directly dem-
onstrates that the substrate employed in these experi-
ments could access the polymerase within the
permeabilized viral core particles.
Figure 4
RNAseH assay using micrococcal nuclease treated cores after permeabilization. Wild type viral core particles (DHBV) or
reverse transcriptase-activity deficient core particles (DHBV-YMHA) were permeabilized and the nucleic acids within the
cores were either digested with micrococcal nuclease (lanes 3-6), or a mock micrococcal nuclease digestion was performed
(lanes 7-10). + indicates a complementary oligonucleotide was included in the reaction; - indicates that the oligonucleotide was
the same polarity as the template; RNAseH indicates E. coli RNAseH; 'No core' indicates the DHBV cores were omitted from
the reaction. The sizes of the substrate (265 nt) and its cleavage products (152 nt and 93 nt) are marked.BMC Microbiology 2001, 1 http://www.biomedcentral.com/1471-2180/1/12
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Survey of reaction conditions
The initial RNAseH assays were performed under condi-
tions optimized for the reverse transcriptase activity of re-
combinant DHBV P [29]. These conditions were chosen
because the RNAseH and polymerase activities function
coordinately during reverse transcription, and hence it is
reasonable to assume they operate under similar condi-
tions. However, because the initial assays failed to detect
DHBV RNAseH activity, the oligonucleotide-directed
RNAseH assay was performed with DHBV cores under a
wide variety of conditions. We first employed conditions
optimized for human immunodeficiency virus RNAseH
[30]. RNAseH activity was detected using E. coli RNAseH
and AMV reverse transcriptase, but it was not detected
with the DHBV cores (data not shown). We then varied
the pH from 7.0 to 8.5; E. coli RNAseH was active at all
pHs, but no cleavage was found in reactions containing
the permeabilized cores (data not shown). Negative re-
sults for DHBV RNAseH activity were also obtained when
the RNAseH assay was performed at NaCl concentrations
ranging from 50–150 mM, although the E. coli RNAseH
was active in all these conditions (data not shown). To ex-
amine the effect of divalent cation composition, 8 mM
MnCl2, was used instead of 10 mM MgCl2, and again no
RNAseH activity was detected (data not shown). We next
examined cleavage with substrate amounts ranging from
50 ng to 5000 ng per reaction and with incubation times
ranging from 1 h to 4 h. DHBV RNAseH cleavage was not
detected under any of these conditions, although the E.
coli RNAseH activity was detected in all of them (data not
shown). Since the body temperature of Pekin ducks is
about 42°C, an RNAseH assay was performed with DHBV
cores at 42°C. Again, no RNAseH activity was observed
(data not shown).
ATP has been reported to increase the cleavage efficiency
of RNAseH [31]. Therefore, 1.5 mM ATP was included in
an RNAseH assay. DHBV RNAseH cleavage was not de-
tected within the cores under these conditions (data not
shown). Similarly, inclusion of 40 µM each of the four
dNTPs did not stimulate the RNAseH activity (data not
shown). This suggests that (i) there is no obvious nucle-
otide requirement to activate the RNAseH activity, and (ii)
any DNA synthesis that may have occurred on the sub-
strates during the reaction (either primed by the oligonu-
cleotide or produced by the trans reaction) was
insufficient to induce detectable RNAseH activity.
To detect DNA polymerization on exogenous RNA tem-
plates (the trans-reaction), the endogenous nucleic acids
are first removed with micrococcal nuclease. To determine
if a similar effect would be observed with the RNAseH ac-
tivity, an RNAseH assay was performed in permeabilized
cores in which the nucleic acids had been removed with
micrococcal nuclease. The results (Fig. 4) showed that
RNAseH activity was not detected in micrococcal nuclease
treated cores (lanes 3 to 6). Because the ∈  RNA stem-loop
induces a structural change in P that is required for DHBV
DNA polymerase activity [27, 28], we examined the possi-
bility that ∈  may activate the RNAseH activity in micro-
coccal nuclease treated cores. ∈  RNA was added in trans to
micrococcal nuclease treated cores in the RNAseH assay,
and again, DHBV RNAseH activity was not observed (data
not shown).
Oligonucleotide-directed RNAseH assays with alternate 
substrates
The above experiments suggest that the DHBV RNAseH
may not be able to act on exogenous substrates. To ex-
clude the possibility that the DHBV RNAseH simply could
not recognize the specific heteroduplex formed by DRF+
RNA and oligonucleotide D2507-, a second pair oligonu-
cleotides (D2453+ and D2543M-Sal) were employed with
DRF+ RNA in oligonucleotide-directed RNAseH assays
employing permeabilized DHBV core particles. Again, no
DHBV RNAseH activity was observed with the viral cores
under any condition employed, although E. coli RNAseH
recognized the substrate under all conditions employed
(data not shown). To determine if the lack of success was
specific to the DRF+ RNA, a second RNA, DXB+ (DHBV nt
1358–1504 positive polarity), annealed to the comple-
mentary oligonucleotide D1452- was employed in
RNAseH assays. Again, no specific DHBV RNAseH cleav-
age was observed (data not shown), indicating that using
different region of RNA from the DHBV genome did not
affect the observation that the DHBV RNAseH could not
engage an exogenous substrate. Because the micrococcal
nuclease-treated cores may represent the best likelihood
of observing RNAseH activity, a titration of the substrate
was performed employing 50 to 500 ng DXB+ RNA an-
nealed to D1452- and nuclease-treated DHBV core parti-
cles. Again, no DHBV-specific cleavages were observed
(data not shown).
Alternate RNAseH assays
Other assays to detect DHBV RNAseH activity were also
employed. Randomly initiated RNA synthesis by E. coli
RNA polymerase was used to make [32P]RNA:DNA sub-
strates using synthetic homopolymers or DRF DNA [30].
In these assays, RNAseH activity is measured as a reduc-
tion in TCA-precipitable radioactivity. No viral RNAseH
activity was detected in experiments with DHBV cores,
supporting the observation obtained with the oligonucle-
otide-directed RNAseH assay (data not shown).
Two different sources of recombinant, enzymatically ac-
tive DHBV P were also employed in the RNAseH assays
without success. DHBV P with reverse transcriptase activi-
ty can be produced in yeast within recombinant TY retro-
transposnon particles as a fusion with yeastBMC Microbiology 2001, 1 http://www.biomedcentral.com/1471-2180/1/12
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retrotransposon TY-A protein [29]. DHBV RNAseH activi-
ty could not be detected using yeast-derived recombinant
P in either the oligonucleotide-directed RNAseH assay or
the synthetic homopolymer assay, although RNAseH ac-
tivity of the wild-type TY retrotransposon particles could
be detected (data not shown). DHBV RNAseH activity
also could not be detected with P translated in vitro in rab-
bit reticulocyte lysates, although P expressed in this sys-
tem possesses reverse transcriptase activity [7].
Discussion
The hepadnaviral DNA polymerase activity is strongly as-
sociated with the viral core structure and is normally una-
ble to synthesize DNA from an exogenous template [16].
The aim of this study was to determine if the DHBV
RNAseH activity was similarly restricted to the endog-
enous heteroduplex substrate generated during reverse
transcription. Oligonucleotide-directed RNAseH assays
were performed with permeabilized viral cores under a
wide variety of conditions. Temperature, pH, cation com-
position, salt concentration, substrate concentration, and
inclusion of ATP and dNTPs were examined. RNAseH as-
says were also carried out after removal of the endogenous
nucleic acid, and multiple RNA sequences and DNA oligo-
nucleotide combinations were employed. DHBV RNAseH
activity was not detected under any of these conditions, al-
though E. coli or AMV RNAseH activity could easily be de-
tected under all of them.
Control experiments demonstrated that (i) the cores were
permeabilized because the viral nucleic acids were sensi-
tive to micrococcal nuclease following low pH treatment;
(ii) the RNAseH substrate could access the polymerase
within the viral cores as determined by the trans reaction
(Fig. 3B); (iii) the DNA polymerase activity of the P sur-
vived the low pH treatment, as measured by synthesis of
viral DNA; and (iv) the RNAseH substrates were suitable
because they were degraded by E. coli RNAseH and AMV
reverse transcriptase and because the DHBV RNAseH ac-
tivity can degrade these RNA sequences during reverse
transcription (the target RNAs were derived from the
DHBV genome). However, the DHBV RNAseH activity
could not degrade the same sequences when they were
presented as exogenous heteroduplexes. Therefore, we feel
the RNAseH activity is likely to be "substrate committed"
in a manner analogous to the template commitment of
the DNA polymerase activity.
This conclusion is subject to a number of caveats because
it rests on negative data (i.e., the failure to detect RNAseH
activity). There are at least three other potential causes for
the failure to detect RNAseH activity that we cannot for-
mally exclude. The first possible cause is that the RNAseH
activity in our core preparations may be too low to detect.
To evaluate this possibility, it is useful to compare the en-
zymatic turnover number for the polymerase activity in
the  trans reaction with the turnover number for the
RNAseH activity that would be needed to reach the detec-
tion limit in our assays. Phosphorimage analysis of the ra-
dioactivity incorporated in a trans reaction employing 1.2
×  109 core particles (quantitated as genome-equivalents of
viral DNA by slot-blot hybridization) indicated that about
4.8 ×  1010 nucleotides were incorporated into DNA in the
reaction. Assuming one polymerase molecule per core
particle, this gives a turnover rate of about 40 nucleotides
per polymerase molecule in the trans reaction. To maxi-
mize the possibility of detecting RNAseH cleavage prod-
ucts, each RNAseH assay was exposed to film for up to a
week to "burn out" the signal from the cleavage products
that migrate below the input RNA on the gels. Under these
conditions, our detection limit for the RNAseH assay was
measured at 0.625 pg of internally 32P-labeled RNA, or
about 7.5 ×  106 molecules of the 152 nt cleavage product.
To reach this detection limit with the 8 ×  109 polymerase
molecules used in a typical RNAseH assay would require
just a single catalytic cycle from 0.094% of the polymerase
molecules in the reaction. Therefore, the turnover number
for the RNAseH activity needed to reach the detection lim-
it in our assays is about 43,000-fold less than the 40 cycles
observed for the polymerase activity under very similar
conditions. This huge difference gives us confidence that
our assays were sensitive enough to detect RNAseH activi-
ty if it were present.
The second alternative cause for our failure to detect
RNAseH activity is that the RNAseH active site may be
sterically blocked in core particles. However, recombinant
P translated in vitro has reverse transcriptase activity out-
side core particles, yet P expressed in this manner was still
unable to degrade the exogenous RNAseH substrates. Fur-
thermore, the DNA polymerase active site in permeabi-
lized core particles is accessible to the exogenous RNAseH
substrates (Fig. 3B). The RNAseH active site must be in
very close proximity to the polymerase site and be orient-
ed in such a manner that it can access heteroduplexes
within ∼  18 base pairs of the 3' end of the growing DNA
chain, and hence steric occlusion seems to be unlikely.
The third alternative explanation for our negative data is
that the DHBV RNAseH activity may have been inactivat-
ed by the low pH pulse used to permeabilize the cores. To
control for this possibility, we employed three different
permeabilization methods (low pH, high salt, and deter-
gent). None of these conditions inactivated the DNA
polymerase activity, yet we were unable to detect RNAseH
activity in cores permeabilized by any of these methods.
Furthermore, DHBV RNAseH activity could not be detect-
ed with recombinant P-TY particles purified from yeast, al-
though TY RNAseH activity could be detected from non-
recombinant TY particles. TY particles are naturally po-
rous and do not require permeabilization for access ofBMC Microbiology 2001, 1 http://www.biomedcentral.com/1471-2180/1/12
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substrate. This allowed us to assay enzymatically active re-
combinant DHBV polymerase for RNAseH activity on ex-
ogenous substrates without permeabilization. Together,
these extensive controls lead us to believe that the sim-
plest explanation of our data, e.g. that the RNAseH activity
is substrate committed, is most probably correct.
The two enzymatic active sites of DHBV P are likely to in-
teract with the viral nucleic acids through a single binding
interaction because they are very close to each other and
because other reverse transcriptases (such as that of HIV)
bind to the RNA:DNA heteroduplex as a single protein en-
tity [32]. Therefore, our data imply that the template/sub-
strate commitment of the DHBV reverse transcriptase may
be a feature of that common interaction rather than a fea-
ture of the polymerase active site alone. This hypothesis is
consistent with the recent production of enzymatically ac-
tive HBV RNAseH as a fusion protein in E. coli [24] be-
cause the fusion protein did not contain the polymerase
domain and it was not substrate committed. Because one
biochemical feature (e.g., substrate commitment) of this
recombinant HBV RNAseH enzyme may be altered rela-
tive to the properties of the native enzyme, the possibility
that other biochemical parameters of the recombinant en-
zyme may differ from those of the native enzyme should
be considered.
The molecular mechanism of this probable template/sub-
strate commitment is unclear. We speculate that the cova-
lent linkage of the viral DNA to P or an unusually tight
association between P and the viral nucleic acids may con-
tribute to the commitment. However, this cannot entirely
account for the substrate commitment because removal of
endogenous nucleic acid with micrococcal nuclease only
partially relieves the template commitment of the DNA
polymerase activity and it did not relieve the apparent re-
striction on the RNAseH activity. Understanding the
mechanism of the template/substrate commitment of the
hepadnaviral reverse transcriptase may need to wait until
a three-dimensional structure of the polymerase bound to
a nucleic acid primer-template is obtained.
Conclusions
DHBV RNAseH activity could be detected on RNA:DNA
heteroduplexes synthesized within DHBV core particles in
the process of viral reverse transcription, but no RNAseH
activity could be detected exogenously provided
RNA:DNA heteroduplexes. Extensive controls lead us to
believe that the RNAseH active site is most probably "sub-
strate committed" in a manner similar to the "template
commitment" of the reverse transcriptase activity. We ac-
knowledge that we have not formally proven this conclu-
sion, but at a minimum, we have demonstrated that the
DHBV RNAseH activity cannot degrade exogenous sub-
strates under a very wide variety of conditions that sup-
port vigorous activity by the associated DNA polymerase
domain.
Materials and Methods
Viruses, DNA constructs, and oligonucleotides
The vims employed in this study was duck hepatitis B Vi-
rus Type 3 (DHBV3; [33]). The vector for all constructs
was pBluescript(-) (Stratagene). D1.5G is an overlength
wild-type DHBV3 expression construct that contains a 5'
duplication of nt 1658 to 3021. D1.5G-D715V and
D1.5G-YMHA are mutant derivatives of D1.5G. D1.5G-
D715V contains a mutation that alters P amino acid 715D
to V; this alteration ablates the RNAseH activity [23].
D1.5G-YMHA contains mutations in the reverse tran-
scriptase motif YMDD of P (D513H and D514A) that ab-
late DNA polymerization [17]. pDRF contains DHBV nt
2401 to 2605. pDXB contains DHBV nt 1358 to 2662.
Three pairs of complementary oligonucleotides were used
in this study. The D2526+/D2507- and D2453+/
D2543M-Sal pairs were used with DRF+ RNA, and the
D1433+/ D1452- pair was used with DXB+ RNA. The se-
quences of the oligonucleotides are: D2526+ (CCACAT-
AGGCTATGTGGAAC), D2507-
(GTTCCACATAGCCTATGTGG), D2453+ (CCGCCT-
GATTGG ACGGCTTTTCC),D2543M-Sal (GCAACTGT-
GTCGACAGCAGCTCCGAAGGAGA), D1433+
(CCAAGATACTGGAGCCCAAA), and D1452- (TTT-
GGGCTCCAGTATCTTGG).
Transfection, isolation, and permeabilization of viral cores
LMH cells were transfected by calcium phosphate copre-
cipitation as described previously [6], and viral cores were
isolated 3 days post-transfection. The transfected cells
were lysed in 1 ml lysis buffer [10 mM Tris-HCl (pH 7.5),
1 mM EDTA, 0.25% Nonidet P-40, 50 mM NaCl, 8% su-
crose] per 100 mm plate at 37°C for 10 min. The cell lysate
was clarified at 13,000× g for 5 min and digested with 100
units micrococcal nuclease (Roche) for 45 min at 37°C in
the presence of 10 mM CaCl2. Digestion was stopped by
addition of EDTA to 15 mM, and then the lysate was clar-
ified again by centrifugation at 13,000× g for 5 min. The
supernatant was layered on a 30% sucrose cushion and
centrifuged at 245,000× g for 2 h at 4°C. The pellet was re-
suspended in 50 µl B/EDTA/sucrose (10 mM HEPES pH
7.8, 15 mM KCl, 5 mM EDTA, 5% sucrose) and stored at -
75°C. Viral cores were permeabilized by a 30 second treat-
ment at pH 2.5 as described [16]. For mock permeabiliza-
tion of cores, the glycine and Tris-HCl used to lower the
pH and to neutralize the solution during permeabiliza-
tion were mixed together prior to addition to core parti-
cles.BMC Microbiology 2001, 1 http://www.biomedcentral.com/1471-2180/1/12
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In vitro transcription and purification of RNA templates
pDRF and pDXB were used for the production of internal-
ly  32P -labeled RNA substrates by in vitro transcription
with the appropriate Megascript kit (Ambion) with addi-
tion of 20 µCi [α 32P]UTP (Amersham). pDRF was linear-
ized with EcoRI and transcribed by T3 RNA polymerase;
the resulting RNA was 265nt long with positive polarity.
pDXB was linearized with AvaII and was transcribed with
T7 RNA polymerase; the resulting RNA was 182 nt long
with positive polarity. Following the transcription, the
DNA templates were digested with DNaseI. RNA tran-
scripts were gel purified by resolving them on 6% denatur-
ing PAGE, excising them, and eluting them in a buffer
containing 0.5 M ammonium acetate, 1 mM EDTA and
0.1%SDS overnight prior to phenol extraction and etha-
nol precipitation.
Oligonucleotide-directed RNAseH assay
RNAseH activity in permeabilized cores was measured by
oligonucleotide-directed cleavage of internally 32P-la-
beled RNA substrates. The reaction was performed in en-
dogenous polymerase buffer (50 mM Tris-HCl pH 8.0,
100 mM NaCl, 0.1% NP-40, 10 mM MgCl2 2.5% 2-mer-
captoethanol) with 1 µg oligonucleotide, 100 ng purified
radiolabeled RNA template, and 4 U RNasin at 37°C for
65 min. The products were resolved by electrophoresis,
and detected by phosphorimage analysis (Molecular Dy-
namics). In some cases, 50 mM Tris-HCl pH 8.0, 2 mM
DTT, 100 µg/ml BSA, 50 mM KCl and 8 mM MgCl2 was
used (retroviral reverse transcriptase buffer [30]). E. coli
RNAseH (0.5 U; Promega) was used as a positive control.
Endogenous polymerase reaction
Reverse transcriptase activity in viral cores was assayed by
incubating cores in endogenous polymerase buffer with
40 µM dATP, dCTP, dTTP and 2 µCi [α 32P]dGTP (Amer-
sham) at 37°C for 90 min. The mixture was digested with
400 µg/ml proteinase K in the presence of 1% SDS for 2 h
at 37°C. After phenol and chloroform extraction, the DNA
was precipitated with ethanol, resolved on a 1.2% agarose
gel and detected by autoradiography.
DNA synthesis on exogenous RNA templates
Reverse transcriptase activity using an exogenous RNA
template was measured as described previously [27, 28].
Nucleic acids within permeabilized cores were digested
with micrococcal nuclease in the presence of CaCl2 Micro-
coccal nuclease was inactivated by addition of EGTA, 1.5
µg RNA was added, and the reaction was performed under
conditions described for the endogenous polymerase re-
action. Reactions were stopped by phenol and chloroform
extraction, and the nucleic acids were precipitated with
ethanol. The samples were resolved in 6% denaturing
polyacrylamide gels and detected by phosphorimage
analysis. For mock micrococcal nuclease treatment, the
CaCl2 micrococcal nuclease and EGTA were mixed prior
to addition to the permeabilized cores.
List of Abbreviations
AMV, Avian Myeloblastosis Virus
DHBV, Duck Hepatitis B Virus
dNTPs, deoxynucleotide triphosphates
EGTA, [ethylenebis(oxyethylenenitrilo)]tetra acetic acid
HBV, Hepatitis B Virus
nt, nucleotide
P, polymerase or reverse transcriptase
RNAseH, ribonuclease H
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